How to Develop and Implement a National Drug Policy - WHO Policy Perspectives on Medicines, No. 006, January 2003
(2003; 6 pages) [French] [Spanish] Voir le document au format PDF
Table des matières
Afficher le documentWhat is a national drug policy?
Afficher le documentObjectives of a national drug policy
Afficher le documentThe essential medicine concept is central to a national drug policy
Afficher le documentThe national drug policy process
Fermer ce répertoireKey components of a national drug policy
Afficher le documentSelection of essential medicines
Afficher le documentAffordability
Afficher le documentFinancing options
Afficher le documentSupply systems
Afficher le documentRegulation and quality assurance
Afficher le documentRational use
Afficher le documentResearch
Afficher le documentHuman resources development
Afficher le documentMonitoring and evaluation
Afficher le documentKey documents
 

Regulation and quality assurance

The drug regulatory authority is the agency that develops and implements most of the legislation and regulations on pharmaceuticals, to ensure the quality, safety and efficacy of medicines, and the accuracy of product information. This is done by making certain that the manufacture, procurement, import, export, distribution, supply and sale of drugs, product promotion and advertising, and clinical trials are carried out according to specified standards.

Drug regulation is a complex task, with many stakeholders and vested interests involved. For this reason there are a number of basic requirements:

• Government commitment to drug regulation, including the need to ensure a sound legal basis and adequate human and financial resources;

• Independence of the regulatory authority to ensure that there is no conflict of interest;

• Commitment to good manufacturing practices, inspection and law enforcement;

• Regulation of traditional and herbal medicines;

• Ensuring adverse drug reaction monitoring systems;

• Commitment to regulation of information and drug promotion;

• International exchange of information.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013